News

New and renewed Canada Research Chair appointments are worth $2.9 million in funding.

Scientists have uncovered a surprising way to reduce the brain damage caused by head injuries stopping the body's immune system from killing brain cells. The study, published in the open access journal Acta Neuropathologica Communications, showed that in experiments on mice, an immune-based treatment reduced the size of brain lesions.

Infection with herpes simplex virus increases the risk of Alzheimer's disease. Researchers at Umeå University claim this in two studies in the journal Alzheimer’s & Dementia.

A drug being studied as a fast-acting mood-lifter restored pleasure-seeking behavior independent of — and ahead of — its other antidepressant effects, in a National Institutes of Health trial.

Researchers from the Perelman School of Medicine and School of Engineering at the University of Pennsylvania and The Children's Hospital of Philadelphia have used graphene- a two-dimensional form of carbon only one atom thick- to fabricate a new type of microelectrode that solves a major problem for investigators looking to understand the intricate circuitry of the brain.

Ximbio aims to change the way reagents are searched, sourced and shared.

Multi-year research agreement for development and application of SomaLogic’s unique proteomics technology to Novartis’ drug discovery and development efforts.

Partnership established to develop novel target enrichment technologies for next generation sequencing.

Partnership aims to develop novel target enrichment technologies for Next Generation Sequencing.

Three-dimensional system should significantly reduce time and costs of drug development.